Company intelligence / Profile preview

NuevaBio

Palo Alto, California, United Statesnuevabio.com ↗

Ownership: Private
Development stage: Other

Overview

NuevaBio is an investment firm established in 2022 that founds, seeds, and grows innovative companies in the life sciences sector. It is based in Palo Alto, California. The firm has played a significant role as founder and investor in companies such as OrsoBio and MitoPower[1][2][3]. NuevaBio itself does not conduct drug development but enables it through its portfolio companies. Its most notable portfolio company, OrsoBio, develops therapies for metabolic diseases including obesity and type 2 diabetes[1][4].

Industry: Investors

Beyond the preview

Go deeper on NuevaBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NuevaBio.

Explore the full profile